Antigenics Inc.

Antigenics Inc.
Search
Products and TechnologiesClinical TrialsNewsroomInvestorsJobsAbout Antigenics

Contact Investor Relations

Below you can quickly e-mail or request materials from our investor relations department. Fields marked with an asterisk (*) are required.

If you prefer, you may call our toll-free number at 800.962.AGEN (2436).

YOUR CONTACT INFORMATION  
*Name
Title
Company
*E-mail
Phone
     
REQUEST MATERIALS   Please select one or more items you would like to receive:

 10-K/Annual Report (postal mail) (or download here)
 Antigenics news and press releases (e-mail) (view online)
 Proxy statement (postal mail) (view online)
 Investor kit (postal mail)


If you’ve checked any items to be shipped via postal mail, please tell us your mailing address:

Address 1
Address 2
City
State
Zip
     
SEND A MESSAGE OR OTHER REQUESTS   E-mail Investor Relations:

Subject
Message
  We respect your privacy. All personal information you provide to us will be treated with the greatest confidentiality and will be used only to fulfill your request or respond to your inquiry. By submitting this form, you indicate that you are providing us with your information voluntarily. For more information, please read our complete privacy policy.

Antigenics home pageSitemap for antigenics.comGlossaryContact Antigenics